In the news
Biosimilars Can Help Lower Patient Drug Costs When the Right Teams Come Together: Prime Therapeutics Executive
May 29, 2022Managed Healthcare Executive
Related news
In the news
May 5, 2022
Prime Therapeutics buying Magellan Health’s pharma business for $1.35 billion
Minneapolis/St. Paul Business Journal
In the news
May 5, 2022
Prime Therapeutics paying $1.35 billion for Magellan Health’s pharmacy business
Star Tribune